Alteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and d-galactose
- 26 May 2009
- journal article
- research article
- Published by Springer Nature in AGE
- Vol. 31 (4) , 277-284
Abstract
The purpose of this study was to look for alterations in β-amyloid peptide (Aβ) metabolism-related molecules in predementia, the early stage of Alzheimer’s disease (AD). AlCl3 (Al) and d-galactose (D-gal) were used to induce the mouse model for predementia and AD. Protein expression of β-amyloid (Aβ), β-secretase (BACE1), neprilysin (NEP), insulin degrading enzyme (IDE) and receptor for advanced glycation end products (RAGE) in the brain was measured. The results indicated that Al + D-gal induced an AD-like behavioral deficit at 90 days. The period from 45 to 75 days showed no significant behavioral deficit, and we tentatively define this as predementia in this model. A significant increase in BACE1 and decreasing NEP characterized days 45–90 in the cortex and hippocampus. However, high Aβ occurred at day 60. IDE increased from day 60 to day 75. There was no change in RAGE. The results suggest that the observed changes in BACE1, NEP and Aβ in predementia might relate to a different stage of the AD-like pathology, which may be developed into useful biomarkers for the diagnosis of very early AD.Keywords
This publication has 44 references indexed in Scilit:
- Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's diseaseBrain Research, 2008
- Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosisJournal of Neurochemistry, 2008
- Hippocampal hypometabolism predicts cognitive decline from normal agingNeurobiology of Aging, 2008
- S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin DomainsJournal of Biological Chemistry, 2007
- BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic miceNeurobiology of Disease, 2007
- Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotectionProceedings of the National Academy of Sciences, 2006
- Alzheimer's diseaseThe Lancet, 2006
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1Journal of Biological Chemistry, 2004
- Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzymeFEBS Letters, 1994